Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

800500

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Scarlet Fever
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the reasons for the recent rise in scarlet fever cases across England.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	117121
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>Public Health England has undertaken detailed analysis of scarlet fever notifications in England and Wales, collected as part of the statutory notifications of infectious diseases, to understand the possible cause of the rise in scarlet fever cases. Assessment of strains collected from scarlet fever patients across England as part of this investigation ruled out the emergence of a new strain as the cause of this rise. Longitudinal assessment of notifications since 1911 identified periodic surges in disease but all of relatively smaller magnitude to that seen during this current resurgence. The assessment is available at:</p><p><a href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30693-X/fulltext?elsca1=tlpr" target="_blank">http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30693-X/fulltext?elsca1=tlpr</a></p><p>The data collected has shown that cases reported during the rise are similar to previous cases in terms of seasonal pattern of occurrence, demographic characteristics, and frequency of hospitalisation.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 15:13:24 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

800513

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Biosimilar Medicines
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, whether NHS England has provided any guidance to hospital trusts and clinicians on the introduction of a biosimilar of Herceptin (trastuzumab) for breast cancer.
tabling member constituency	West Ham
tabling member printed	Lyn Brown
uin	117134
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>A final date for the availability of a biosimilar of Herceptin (trastuzumab) has yet to be agreed. Therefore NHS England has not yet issued any guidance on the introduction of a biosimilar of Herceptin (trastuzumab) for breast cancer. However, NHS England has discussed the introduction and uptake of biosimilar trastuzumab with the Cancer Vanguard. The Vanguard is a group of National Health Service trusts looking at developing new models of care and providing replicable models for cancer care nationally that will act as blueprints for the NHS.</p><p> </p><p>The Cancer Vanguard will provide guidance and supporting documentation to hospital trusts and clinicians in the same way that documents were provided to support the introduction of biosimilar rituximab. Once a firm date is known, NHS trusts will be contacted regarding the availability of biosimilar trastuzumab and what they must do to ensure uptake. This will include linkages to the supporting documents issued by the Vanguard.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2017 17:11:26 answering member 4067 label Biography information for Steve Brine
tabling member	1583 label Biography information for Ms Lyn Brown

800571

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neuromuscular Disorders
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the (a) extent and (b) effect on patient care of variation in specialist services for multiple sclerosis and Parkinson's among clinical commissioning groups in England.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	117192
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>We know that variation exists between clinical commissioning groups (CCGs) in the provision of care for neurological conditions, such as Parkinson’s disease and multiple sclerosis. Whilst it is right that CCGs have autonomy to shape services for local populations, there is a range of work ongoing at a national level to identify unwarranted variation in order to drive improvement, including:</p><p> </p><p>- Through the RightCare programme, which was rolled out to every CCG in 2016/17, NHS England provides practical support to commissioners to tackle unwarranted variation and identify improvements and savings, including for neurological services;</p><p>- Public Health England’s Neurology intelligence network collates and interprets data on adult neurological conditions to provide intelligence for the National Health Service, policy makers, and clinicians; and</p><p>- The Getting it Right First Time programme, supported by NHS Improvement, expanded earlier in 2017 to include neurology and will soon provide insight to demonstrate the value of better neurological services both in hospitals and in the community.</p><p> </p><p>NHS England will continue to work with the Neurological Alliance (an umbrella organisation for neurological condition charities) to support the new national Neurology Advisory Group (NAG), led by consultant neurologist Professor Adrian Williams. The NAG brings together system partners, professional bodies stakeholders to align work to improve neurological care, and has working to understand how best to utilise new and emerging data in services and outcomes. More information on national initiatives to reduce unwarranted variation and drive improvement can be found at the following links:</p><p> </p><p><a href="http://www.england.nhs.uk/rightcare/" target="_blank">www.england.nhs.uk/rightcare/</a></p><p> </p><p><a href="http://www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals" target="_blank">www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals</a></p><p> </p><p><a href="http://gettingitrightfirsttime.co.uk/" target="_blank">gettingitrightfirsttime.co.uk/</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 117193 question first answered 12/12/2017 17:07:27 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

800572

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Neuromuscular Disorders
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the potential for improved specialist services for multiple sclerosis and Parkinson's delivering significant savings for the NHS; and if he will make a statement.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	117193
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>We know that variation exists between clinical commissioning groups (CCGs) in the provision of care for neurological conditions, such as Parkinson’s disease and multiple sclerosis. Whilst it is right that CCGs have autonomy to shape services for local populations, there is a range of work ongoing at a national level to identify unwarranted variation in order to drive improvement, including:</p><p> </p><p>- Through the RightCare programme, which was rolled out to every CCG in 2016/17, NHS England provides practical support to commissioners to tackle unwarranted variation and identify improvements and savings, including for neurological services;</p><p>- Public Health England’s Neurology intelligence network collates and interprets data on adult neurological conditions to provide intelligence for the National Health Service, policy makers, and clinicians; and</p><p>- The Getting it Right First Time programme, supported by NHS Improvement, expanded earlier in 2017 to include neurology and will soon provide insight to demonstrate the value of better neurological services both in hospitals and in the community.</p><p> </p><p>NHS England will continue to work with the Neurological Alliance (an umbrella organisation for neurological condition charities) to support the new national Neurology Advisory Group (NAG), led by consultant neurologist Professor Adrian Williams. The NAG brings together system partners, professional bodies stakeholders to align work to improve neurological care, and has working to understand how best to utilise new and emerging data in services and outcomes. More information on national initiatives to reduce unwarranted variation and drive improvement can be found at the following links:</p><p> </p><p><a href="http://www.england.nhs.uk/rightcare/" target="_blank">www.england.nhs.uk/rightcare/</a></p><p> </p><p><a href="http://www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals" target="_blank">www.gov.uk/guidance/neurology-data-and-analysis-a-guide-for-health-professionals</a></p><p> </p><p><a href="http://gettingitrightfirsttime.co.uk/" target="_blank">gettingitrightfirsttime.co.uk/</a></p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 117192 question first answered 12/12/2017 17:07:27 answering member 4067 label Biography information for Steve Brine
tabling member	4079 label Biography information for Julian Sturdy

800580

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Incinerators: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of the use of waste incinerators on health.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	117201
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>The effects of modern municipal waste incinerators on human health were reviewed by the Health Protection Agency, whose functions were transferred to Public Health England (PHE) 1 April 2013. The report, published in September 2009, concluded “Modern, well managed incinerators make only a small contribution to local concentrations of air pollutants. It is possible that such small additions could have an impact on health but such effects, if they exist, are likely to be very small and not detectable.”</p><p> </p><p>PHE will review its advice in light of new substantial research on the health effects of incinerators published in peer reviewed journals. To date, PHE is not aware of any evidence that requires a change in their position statement.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2017 13:57:01 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

800616

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, To ask the Secretary of State for Health, with reference to the report by Action for ME, Spotlight on specialist services: UK healthcare for people with ME, published in July 2017, what assessment his Department has made of the feasibility of collecting data on the prevalence of ME for each Clinical Commissioning Group area.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	117237
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>No assessment has been made.</p><p> </p><p>The National Institute for Health and Care Excellence reports that the annual estimated prevalence is at least 0.2–0.4% (around 190,000) in the United Kingdom. Population prevalence estimates, along with data on services usage and other local intelligence can support commissioners to deliver high quality services for the populations they serve.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 16:56:24 answering member 4067 label Biography information for Steve Brine
tabling member	4658 label Biography information for Alex Sobel

800658

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the level of childhood obesity was in each region of England in each year for which data is available and what estimate he has made of the levels of childhood obesity in each of the next five years.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	117279
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>Data on the level of childhood obesity in each region of England can be found in the attached documents ‘Obesity Prevalence in Reception’ and ‘Obesity Prevalence in Year 6’.</p><p> </p><p>No estimate of the levels of childhood obesity in each of the next five years has been made.</p> answering member constituency Winchester answering member printed Steve Brine attachment 1 file name Obesity Prevalence in Year 6.pdf title PQ117279 attached doc. 2 file name Obesity Prevalence in Reception.pdf title PQ117279 attached doc. question first answered 12/12/2017 12:29:13 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

800659

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of excess sugar consumption on levels of childhood obesity.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	117280
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The 2015 Scientific Advisory Committee on Nutrition (SACN) Carbohydrate and Health report provided an assessment of the impact of excess sugar consumption and concluded that a diet high in sugar increases the risk of weight gain. SACN also recommended that intakes of sugar should not exceed five percent of total energy, a halving of the previous recommendation. The report is available at:</p><p><a href="https://www.gov.uk/government/publications/sacn-carbohydrates-and-health-report" target="_blank">https://www.gov.uk/government/publications/sacn-carbohydrates-and-health-report</a></p><p>The 2016 National Diet and Nutrition Survey shows that children’s intakes of sugar are at around three times recommended levels. The survey is available at:</p><p><a href="https://www.gov.uk/government/collections/national-diet-and-nutrition-survey" target="_blank">https://www.gov.uk/government/collections/national-diet-and-nutrition-survey</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:48:42 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

800660

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of targeting food and drink advertising at children and young people on the level of childhood obesity.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	117281
answer	answer is ministerial correction date of answer 12/12/2017 answer text <p>Public Health England’s 2015 report ‘Sugar reduction: The evidence for action’ is available at:</p><p><a href="https://www.gov.uk/government/publications/sugar-reduction-from-evidence-into-action" target="_blank">https://www.gov.uk/government/publications/sugar-reduction-from-evidence-into-action</a></p><p>The report showed that all forms of advertising and marketing, including advertising on television, through social and other online media, increase the preference, choice, purchasing and consumption of high sugar foods and drinks by children. Consuming a diet high in sugar leads to weight gain and therefore contributes to childhood obesity.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 12/12/2017 12:39:56 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

800673

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Leukaemia: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment he has made of the adequacy of the provision of treatment for people diagnosed with Juvenile Myelomonocytic Leukemia.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	117294
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>The usual treatment for juvenile myelomonocytic leukaemia is a stem cell transplant, the only type of treatment that can currently cure the disease. Unfortunately, this type of treatment is only suitable for some children. Currently NHS England commissions stem cell transplants from 12 providers across England. Doctors and scientists are trying to improve the treatment of this condition through both National Health Service funded and charitable means, however at this time it remains difficult to cure.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 16:58:14 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham